Module 8 : GENE THERAPY : INTRODUCTION AND METHODS

Lecture 1 : Gene Therapy: Introduction and Methods

Bibliography

Bainbridge, J. W. B.; Smith, A. J.; Barker, S. S.; Robbie, S.; Henderson, R.; Balaggan, K.; Viswanathan, A.; Holder, G. E. et al. (2008). "Effect of Gene Therapy on Visual Function in Leber's Congenital Amaurosis". New England Journal of Medicine 358 (21): 2231–2239.

Cartier, N.; Aubourg, P. (2009). "Hematopoietic Stem Cell Transplantation and Hematopoietic Stem Cell Gene Therapy in X-Linked Adrenoleukodystrophy". Brain Pathology 20 (4): 857–862.

Cideciyan, A. V.; Hauswirth, W. W.; Aleman, T. S.; Kaushal, S.; Schwartz, S. B.; Boye, S. L.; Windsor, E. A. M.; Conlon, T. J. et al. (2009). "Vision 1 Year after Gene Therapy for Leber's Congenital Amaurosis". New England Journal of Medicine 361 (7): 725–727.

Coghlan, Andy (11 December 2013) Souped-up immune cells force leukaemia into remission New Scientist, Retrieved 15 April 2013

Coghlan, Andy (26 March 2013) Gene therapy cures leukaemia in eight days The New Scientist, Retrieved 15 April 2013

Ferrua, F.; Brigida, I.; Aiuti, A. (2010). "Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency". Current Opinion in Allergy and Clinical Immunology 10 (6): 551–556. doi:10.1097/ACI.0b013e32833fea85. PMID 20966749.

Fischer, A.; Hacein-Bey-Abina, S.; Cavazzana-Calvo, M. (2010). "20 years of gene therapy for SCID". Nature Immunology 11 (6): 457–460. doi:10.1038/ni0610-457. PMID 20485269.

Griffiths A.J.F, Miller J.H., Suzuki D.T., et al. An Introduction to Genetic Analysis, 7 th ed.; New York: W. H. Freeman; 2000.

Guha C., Ghosh S.S., Lee S.W., Chowdhury N.R., Chowdhury J.R. Madame Curie Bioscience Database [Internet]; Austin (TX): Landes Bioscience; 2000.

Ledford, H. (2011). "Cell therapy fights leukaemia". Nature. doi:10.1038/news.2011.472. edit

Lewitt, P. A.; Rezai, A. R.; Leehey, M. A.; Ojemann, S. G.; Flaherty, A. W.; Eskandar, E. N.; Kostyk, S. K.; Thomas, K. et al. (2011). "AAV2-GAD gene therapy for advanced Parkinson's disease: A double-blind, sham-surgery controlled, randomised trial". The Lancet Neurology 10 (4): 309–319.

Maguire, A. M.; Simonelli, F.; Pierce, E. A.; Pugh, E. N.; Mingozzi, F.; Bennicelli, J.; Banfi, S.; Marshall, K. A. et al. (2008). "Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis". New England Journal of Medicine 358 (21): 2240–2248.

Simonelli, F.; Maguire, A. M.; Testa, F.; Pierce, E. A.; Mingozzi, F.; Bennicelli, J. L.; Rossi, S.; Marshall, K. et al. (2009). "Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration". Molecular Therapy 18 (3): 643–650.

Strachan T., Read A.P. Human Molecular Genetics, 2 nd ed.; New York: Wiley-Liss, 1999; Chapter 22.

Wink M. An Introduction to Molecular Biotechnology, 2 nd ed.; WILEY- VCH Verlag GmbH & Co. KGaA, 2006; pp 523-542.

Ute Fischer, Sabine Steffens, Susanne Frank, Nikolai G Rainov, Klaus Schulze-Osthoff and Christof M Kramm (2005). Mechanism of thymidine kinase/ganciclovir and cytosine deaminase/5-fluorocytosine suicide gene therapy-induced cell death in glioma cells. Oncogene 24 , 1231–1243.

Danthinne X and Imperiale M J(2000). Production of first generation adenovirus vectors: a review. Gene Therapy, 7, 1707-1714

Martin Andreas MückHäusl(2011), Genetic engineering of adenoviral vectors for improved therapeutic applications.

Min Wang, Xinyu Zheng, Xiao-Mei Rao, Hongying Hao, Yanbin Dong, Kelly M. McMasters, and H. Sam Zhou. (2005) Adenoviral vector systems for gene therapy. Gene Ther Mol Biol, Vol 9, 291-300

R Alba, A Bosch and M Chillon (2005). Gutless adenovirus: last-generation adenovirus for gene therapy. Gene Therapy, 12, S18-S27

Cynthia Lyle and Frank McCormick (2010), Integrin αvβ5 is a primary receptor for adenovirus in CAR-negative cells. Virology Journal , 7 :148  Yuanming Zhang and Jeffrey M. Bergelson (2005) Adenovirus Receptors. J Virol ., 79 (19) : 12125–12131

Masaki Uchida, Xiong Wei Li, Peter Mertens, H. Oya Alpar (2009). Transfection by particle bombardment: Delivery of plasmid DNA into mammalian cells using gene gun. Biochimica et Biophysica Acta 1790, 754–764

David S. Strayer,Lokesh Agrawal, Pierre Cordelier, Bianling Liu, Jean-Pierre Louboutin, Elena Marusich, Hayley J. McKee, Carmen N. NiGongyi Ren, and Marlene S. Strayer. (2006). Long-Term Gene Expression in Dividing and Nondividing Cells Using SV40-Derived Vectors. Molecular Biotechnology, Vol. 34, 257-270

Andrew Mountain. (2000) Gene Therapy: the first decade. Trends in Bioetchnology. Volume 18, Issue 3, 1 March 2000, Pages 119–128.

Rashmi Sharma, Ruchi Khajuria, C.L. Sharma, B. Kapoor, K.C. Goswam, K. Kohli. (2004). Gene Therapy: Current Concepts, J.K. Science. Vol. 6 No. 2, page 62-66

Perry B. Hackett, Stephen C. Ekker, David A. Largaespad, R. Scott McIvor. (2005) Sleeping Beauty Transposon ‐ Mediated Gene Therapy for Prolonged Expression. Advances in Genetics. Volume 54, Pages 189–232. Ian R. Graham, George Dickson. (2002) Gene repair and mutagenesis mediated by chimeric RNA–DNA oligonucleotides: chimeraplasty for gene therapy and conversion of single nucleotide polymorphisms (SNPs). Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. Volume 1587, Issue 1, Pages 1–6.

Wanling Liang and Jenny K. W. Lam (2012) Endosomal Escape Pathways for Non-Viral Nucleic Acid Delivery Systems. Molecular Regulation of Endocytosis. Chapter 17